Skip to main content
SpringerLink
Log in

Importance and Benefits of Lifestyles Changes Versus Diabetes Drugs in Effective Management of Diabetes

  • Chapter
  • First Online:
Nutrients, Dietary Supplements, and Nutriceuticals

Part of the book series: Nutrition and Health ((NH))

  • 2167 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. American Diabetes Association. Medical management of type 1 diabetes. 5th ed. Alexandria: American Diabetes Association; 2008.

    Google Scholar 

  2. American Diabetes Association. Medical management of type 2 diabetes. 6th ed. Alexandria: American Diabetes Association; 2008.

    Google Scholar 

  3. American Diabetes Association. Intensive diabetes management. Alexandria: American Diabetes Association; 2003.

    Google Scholar 

  4. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of diabetes mellitus. Diab Care. 1997;20:1183–97.

    Google Scholar 

  5. Moses RG, Cheung NW. Point: universal screening for gestational diabetes mellitus. Diab Care. July 2009;32:1349–51.

    Google Scholar 

  6. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diab Care. 2003;26:3160–7.

    Google Scholar 

  7. Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic ­control. Diab Care. June 2009;32:1119–31.

    Google Scholar 

  8. American Diabetes Association. Standards of medical care in diabetes – 2009. Diab Care. Jan 2009;32:S13–61.

    Google Scholar 

  9. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diab Care. 2007;30:753–9.

    CAS  Google Scholar 

  10. Engelgau MM, Narayan KM, Herman WH. Screening for type 2 diabetes. Diab Care. 2000;23:1563–80.

    CAS  Google Scholar 

  11. McTigue KM, Harris R, Hemphill B, Lux L, Sutton S, Bunton AJ, et al. Screening and interventions for obesity in adults: summary of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2003;139:933–49.

    PubMed  Google Scholar 

  12. American Diabetes Association. Screening for type 2 diabetes. Diab Care. 2004;27 Suppl 1:S11–4.

    Google Scholar 

  13. Nathan DM, Herman WH. Screening for diabetes: can we afford not to screen? Ann Intern Med. May 2004;140(9):756–8.

    PubMed  Google Scholar 

  14. Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diab Care. 2000;23:1108–12.

    CAS  Google Scholar 

  15. Manzella D. Top 7 risk factors for type 2 diabetes. About.com 2009; Updated Feb 2001.

    Google Scholar 

  16. Holt EH. Diabetes risk factors Reviewed on: 6/17/2008

    Google Scholar 

  17. American Diabetes Association. Standards of medical care in diabetes. Diab Care. 2008;31:S12–54.

    Google Scholar 

  18. Hunt D. Foot ulcers and amputations in diabetes. Clin Evid. 2006;15:576–84.

    PubMed  Google Scholar 

  19. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001;345:790–7.

    PubMed  CAS  Google Scholar 

  20. American Diabetes Association (ADA). Standards of medical care in diabetes. IV. 20. Prevention/delay of type 2 diabetes. Diab Care. 2007;30:S7–8.

    Google Scholar 

  21. Inzuchhi SE, Sherwin RS. Type 2 diabetes mellitus. In: Goldman L, Ausiello D, editors. Goldman: Cecil medicine. 23rd ed. Philadelphia: Saunders Elsevier; 2007. Chap. 248.

    Google Scholar 

  22. Diabetes Prevalence and Estimates. NIH Publication No. 08–3892 June 2008 (http://diabetes.niddk.nih.gov/DM/PUBS/statistics/)

  23. Global Prevalence of Diabetes. Estimates for the year 2000 and projections for 2030. WHO Report 2008. http://www.who.int/diabetes/facts/world_figures/en/.

  24. ADA Report. Direct and Indirect Costs of Diabetes in the United States. 2008. http://www.diabetes.org/diabetes-statistics/cost-of-diabetes-in-us.jsp.

  25. MSNBC Data and Report Diabetes could cost U.S. well over $218 billion. 2008. http://www.msnbc.msn.com/id/27783488/.

  26. Engelgau MM, Geiss LS, Saaddine JB, Boyle JP, Benjamin SM, Gregg EW, et al. The evolving diabetes burden in the United States. Ann Intern Med. 2004;140:945–50.

    PubMed  Google Scholar 

  27. Brandle M, Zhou H, Smith BR, Marriott D, Burke R, Tabaei BP, et al. The direct medical cost of type 2 diabetes. Diab Care. 2003;26:2300–4.

    Google Scholar 

  28. Coffey JT, Brandle M, Zhou H, Marriott D, Burke R, Tabaei BP, et al. Valuing health-related quality of life in diabetes. Diab Care. 2002;25:2238–43.

    Google Scholar 

  29. Ubel PA, Hirth RA, Chernew ME, Fendrick AM. What is the price of life and why doesn’t it increase at the rate of inflation? Arch Intern Med. 2003;163:1637–41.

    PubMed  Google Scholar 

  30. Roumen C, Blaak EE, Corpeleijn E. Lifestyle intervention for prevention of diabetes: determinants of success for future implementation. Nutr Rev. 2009;67(3):132–46.

    PubMed  Google Scholar 

  31. King DE, Mainous 3rd AG, Carnemolla M, Everett CJ. Adherence to healthy lifestyle habits in US adults. 1988–2006. Am J Med. 2009;122(6):528–34.

    PubMed  Google Scholar 

  32. Lifestyle prevention: does it work? And why? Harv Mens Health Watch 2009; 13(8):1–4

    Google Scholar 

  33. Maruthur NM, Wang NY, Appel LJ. Lifestyle interventions reduce coronary heart disease risk: results from the PREMIER trial. Circulation. 2009;119(15):2026–31.

    PubMed  Google Scholar 

  34. Ripsin CM, Kang H, Urban RJ. Management of blood glucose in type 2 diabetes mellitus. Am Fam Physician. 2009;79(1):29–36.

    PubMed  Google Scholar 

  35. Gillies L, Lambert PC, Abrams KR, Sutton AJ, Cooper NJ, Hsu RT, et al. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ. 2008;336(7654):1180–5.

    PubMed  Google Scholar 

  36. Jackson L. Translating the diabetes prevention program in to practice: a review of community interventions. Diab Educ. 2009;35(2):309–20.

    Google Scholar 

  37. Brink S. The Diabetes Prevention Program: how the participants did it. Health Aff. 2009;28(1):57–62.

    Google Scholar 

  38. Zimmet P, Shaw J, Alberti KG. Preventing type 2 diabetes and the metabolic syndrome in the real world: a ­realistic view. Diabet Med. 2003;20:693–702.

    PubMed  CAS  Google Scholar 

  39. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.

    PubMed  CAS  Google Scholar 

  40. Caro J, Getsios D, Caro I, Klittich W, O’Brien J. Economic evaluation of therapeutic interventions to prevent type 2 diabetes in Canada. Diabet Med. 2004;21(11):1229–36.

    PubMed  CAS  Google Scholar 

  41. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diab Care. 1997;20:537–44.

    CAS  Google Scholar 

  42. Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, et al. For the Diabetes Prevention Program Research Group. 2005;142(5):323–32.

    Google Scholar 

  43. Mensink M, Feskens EJM, Saris WHM, de Bruin TWA, Blaak EE. Study on lifestyle intervention and impaired glucose tolerance Maastricht (SLIM): preliminary results after one year. Int J Obes Relat Metab Disord. 2003;27:377–84.

    PubMed  CAS  Google Scholar 

  44. Mensink M, Blaak EE, Corpeleijn E, Saris WH, de Bruin TW, Feskens EJ. Lifestyle intervention according to general recommendations improves glucose tolerance. Obes Res. 2003;11:1588–96.

    PubMed  Google Scholar 

  45. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diab Care. 1997;20:537–44.

    CAS  Google Scholar 

  46. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.

    PubMed  CAS  Google Scholar 

  47. The Diabetes Prevention Program (DPP). Description of lifestyle intervention. Diab Care. 2002;25:2165–71.

    Google Scholar 

  48. The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diab Care. 1999;22:623–34.

    Google Scholar 

  49. Jacobs-van der Bruggen MAM, Bos G, Bemelmans WJ, Hoogenveen RT, Vijgen SM, Baan CA. Lifestyle interventions are cost-effective in people with different levels of diabetes risk: results from a modeling study. Diab Care. 2007;30(1):128–34.

    Google Scholar 

  50. Knowler WC, Barrett-Connor E, Fowler SE, Lindstrom J, Louheranta A, Mannelin M, et al. The Finnish Diabetes Prevention Study Group: The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diab Care. 2003;26:3230–6.

    Google Scholar 

  51. Jaakko T. Primary prevention of type 2 diabetes: lifestyle intervention works and saves money, but what should be done with smokers? Annals. 2005;142:381–3.

    Google Scholar 

  52. Modi P. Diabetes beyond insulin; review of new drugs for treatment of diabetes mellitus. Curr Drug Discov Technol. 2007;4:39–47.

    PubMed  CAS  Google Scholar 

  53. Modi P, Mihic M, Metabolic syndrome – risk factors for atherosclerosis and diabetes. Curr Diab Rev, Mar 2008.

    Google Scholar 

  54. American Association of Clinical Endocrinologists. Medical guidelines for the management of diabetes mellitus: the AACE system of intensive diabetes self-management – 2002 update. Endocr Pract. 2002;8 Suppl 1:40–82.

    Google Scholar 

  55. Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson JL, Garg A, et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diab Care. 2003;26 Suppl 1:S51–61.

    Google Scholar 

  56. U.S. Preventive Services Task Force. Behavioral counseling in primary care to promote physical activity: ­recommendations and rationale. Am Fam Physician. 2002;66:1931–6.

    Google Scholar 

  57. Diabetes Prevention Program. Lifestyle manual of operations. http://www.bsc.gwu.edu/dpp/manuals.htmlvdoc (2003). Accessed 25 Aug 2003.

  58. Herman WH. Diabetes modeling [Editorial]. Diab Care. 2003;26:3182–3.

    Google Scholar 

  59. Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess. 2004;8(iii–iv):1–182.

    Google Scholar 

  60. Teutsch S. The cost-effectiveness of preventing diabetes. Diab Care. 2003;26(9):2693–4.

    Google Scholar 

  61. Hoerger TJ, Hicks KA, Sorensen SW, Herman WH, Ratner RE, et al. Cost-effectiveness of screening for ­pre-diabetes among overweight and obese US adults. Diab Care. 2007;30(11):2874–9.

    Google Scholar 

  62. Eddy DM, Schlessinger L, Kahn R. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Ann Intern Med. 2005;143:251–64.

    PubMed  Google Scholar 

  63. The cost-effectiveness of strategies to prevent type 2 diabetes, Annals 2005; 142: I–28

    Google Scholar 

  64. Vijgen SM, Hoogendoorn M, Baan CA, de Wit GA, Limburg W, Feenstra TL. Cost effectiveness of preventive interventions in type 2 diabetes mellitus: a systematic literature review. Pharmacoeconomics. 2006;24:425–41.

    PubMed  Google Scholar 

  65. Monique AM, Jacobs-vander B, Griët B, Bemelmans WJ, Hoogenveen RT, Vijgen SM, et al. Lifestyle ­interventions are cost-effective in people with different levels of diabetes risk. Diab Care. 2007;30:128–34.

    Google Scholar 

  66. Bogers RP, Vijgen SMC, Bemelmans WJE. Costs of lifestyle interventions within health care and the amount of weight loss achieved. Bilthoven: National Institute for Public Health and the Environment; 2006.

    Google Scholar 

  67. Herman WH, Brandle M, Zhang P, Williamson DF, Matulik MJ, Ratner RE, et al. Costs associated with the ­primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diab Care. 2003;26:36–47.

    Google Scholar 

  68. Ritzwoller DP, Toobert D, Sukhanova A, Glasgow RE. Economic analysis of the Mediterranean lifestyle program for postmenopausal women with diabetes. Diab Educ. 2006;32(5):761–9.

    Google Scholar 

  69. Eddy DM, Schlessinger L, Kahn R. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Ann Intern Med. 16 Aug 2005;143(4):251–64.

    PubMed  Google Scholar 

  70. Boren A, Fitzner KA, Panhalkar PS, Specker JE. Costs and benefits associated with diabetes education: a review of the literature. Diab Educ. 1 Jan 2009;35(1):72–96.

    Google Scholar 

  71. Ramachandran A, Snehalatha C, Yamuna A, Mary S, Ping Z. Cost-effectiveness of the interventions in the ­primary prevention of diabetes among Asian Indians: Within trial results of the Indian Diabetes Prevention Programme (IDPP). Diab Care. 1 Oct 2007;30(10):2548–52.

    Google Scholar 

  72. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49:289–97.

    PubMed  CAS  Google Scholar 

  73. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the ­incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.

    PubMed  CAS  Google Scholar 

  74. Diabetes Prevention Program Research Group. Within-trial cost-effectiveness of lifestyle intervention or ­metformin for the primary prevention of Type 2 diabetes. Diab Care. 2003;26:2518–23.

    Google Scholar 

  75. Hamman RF, Lachin JM, Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.

    PubMed  Google Scholar 

  76. Palmer AJ, Roze S, Valentine WJ, Spinas GA, Shaw JE, Zimmet PZ. Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom. Clin Ther. 2004;26:304–21.

    PubMed  Google Scholar 

  77. The Diabetes Prevention Program Research Group. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diab Care. 2003;26:2518–23.

    Google Scholar 

  78. Engelgau RT, Ratner RE. the Diabetes Prevention Program Research Group: The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005;142:323–32.

    PubMed  Google Scholar 

  79. Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, et al. The cost-effectiveness of lifestyle modification or Metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 1 Mar 2005;142(5):323–32.

    PubMed  Google Scholar 

  80. Applying Cost Benefit Analysis to Nutrition Education Programs: Focus on the Virginia Expanded Food and Nutrition Education Program, Publication 490–403, Virginia Polytechnic Institute and State University, Blacksburg. 1 May 2009.

    Google Scholar 

  81. Simmons RK, Harding AH, Jakes RW, Welch A, Wareham NJ, Griffin SJ. How much might achievement of diabetes prevention behavior goals reduce the incidence of diabetes if implemented at the population level? Diabetologia. 2006;49:905–11.

    PubMed  CAS  Google Scholar 

  82. Marrero DG, Ackermann RT. Providing long-term support for lifestyle changes: a key to success in diabetes prevention. Diab Spectr. 1 Oct 2007;20(4):205–9.

    Google Scholar 

  83. Ackermann RT, Marrero DG. Adapting the Diabetes Prevention Program lifestyle intervention for delivery in the community: The YMCA model. Diab Educ. 1 Jan 2007;33(1):69–78.

    Google Scholar 

  84. Centers for Disease Control and Prevention Primary Working Group. Primary prevention of type 2 diabetes mellitus by lifestyle intervention: implications for health policy. Ann Intern Med. 1 June 2004;140(11):951–7.

    Google Scholar 

  85. Zhang P, Engelgau MM, Norris SL, Gregg EW, Venkat Narayan KM. Application of economic analysis to diabetes and diabetes care. Ann Intern Med. 1 June 2004;140(11):972–7.

    PubMed  Google Scholar 

  86. Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, et al. The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diab Care. 1 Dec 2003;26(12):3230–6.

    Google Scholar 

  87. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.

    PubMed  CAS  Google Scholar 

  88. The Diabetes Prevention Program Research Group. Costs associated with the primary prevention of type 2 ­diabetes mellitus in the Diabetes Prevention Program. Diab Care. Jan 2003;26(1):36–47.

    Google Scholar 

  89. Jackson L. Translating the Diabetes Prevention Program into practice: a review of community interventions. Diab Educ. 1 Mar 2009;35:309–20.

    Google Scholar 

  90. Boren SA, Specker JE. Costs and benefits associated with diabetes education: a review of the literature. Diab Educ. 1 Jan 2009;35:72–96.

    Google Scholar 

  91. Koenigsberg MR, Bartlett D, Cramer JS. Facilitating treatment adherence with lifestyle changes in diabetes. Am Fam Physician. 2004;69:309–16.

    PubMed  Google Scholar 

  92. Swinburn B, Egger G. Prevention of type 2 diabetes. Prevention needs to reduce obesogenic environments [Letter]. BMJ. 2001;323:997.

    PubMed  CAS  Google Scholar 

  93. McGinnis JM. Does proof matter? Why strong evidence sometimes yields weak action. Am J Health Promot. 2001;15:391–6.

    PubMed  CAS  Google Scholar 

  94. Segal L, Dalton A, Richardson J. Cost-effectiveness of the primary prevention of non-insulin dependent diabetes mellitus. Health Promot Int. 1998;13:197–210.

    Google Scholar 

  95. The Diabetes Prevention Program Research Group. Costs associated with the primary prevention of type 2 ­diabetes mellitus in the Diabetes Prevention Program. Diab Care. 2003;26:36–47.

    Google Scholar 

  96. The cost-effectiveness of screening for Type 2 diabetes. CDC Diabetes Cost-Effectiveness Study Group, Centers for Disease Control and Prevention. JAMA. 1998;280:1757–63.

    Google Scholar 

  97. Kiss NE. An ethics framework for public health. Am J Public Health. 2001;91:1776–82.

    Google Scholar 

  98. Lenfant C. Shattuck lecture – clinical research to clinical practice – lost in translation? N Engl J Med. 2003;349:868–74.

    PubMed  Google Scholar 

  99. Culyer AJ. Economics and ethics in health care [Editorial]. J Med Ethics. 2001;27:217–22.

    PubMed  CAS  Google Scholar 

  100. Vinicor F. The public health burden of diabetes and the reality of limits. Diab Care. 1998;21 Suppl 3:C15–8.

    Google Scholar 

  101. Vinicor F. Quality of care and diabetes mellitus. Curr Opin Endocrinol Diab. 2001;8:58–66.

    Google Scholar 

  102. Centers for Disease Control and Prevention Primary Prevention Working Group. Supplement: Diabetes Translations and Public Health: 25 Years of CDC Research and Programs, Primary Prevention of Type 2 Diabetes Mellitus by Lifestyle Intervention: Implications for Health Policy. Ann Intern Med. 2004;140:951–7.

    Google Scholar 

  103. Franz MJ, Warshaw H, Daly AE, Green-Pastors J, Arnold MS, Bantle J. Evolution of diabetes medical nutrition therapy. Postgrad Med J. 2003;79:30–5.

    PubMed  CAS  Google Scholar 

  104. American Dietetic Association. Medicare MNT Benefit Provider Information. Available from http://www.­eatright.org. Accessed July 2009.

  105. American Diabetes Association. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications (position statement). Diab Care. 2002;25:202–12.

    Google Scholar 

  106. Franz MJ, Monk A, Barry B, et al. Effectiveness of medical nutrition therapy provided by dietitians in the ­management of non-insulin-dependent diabetes mellitus: a randomized, controlled clinical trial. J Am Diet Assoc. 1995;95:1009–17.

    PubMed  CAS  Google Scholar 

  107. Franz MJ, Bantle JP, Beebe CA, et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications (technical review). Diab Care. 2002;25:1256–8.

    Google Scholar 

  108. Health Promotion International Advance Access originally published online on October 4, 2007. Time to give nutrition interventions a higher profile: cost-effectiveness of 10 nutrition interventions. Health Promot Int. 2007;22 (4):271–83.

    Google Scholar 

  109. Complementary and Alternative Medical Therapies for Diabetes, NIH Publication No. 09-4552, February 2009.

    Google Scholar 

  110. O’Neil CE, Nicklas TA. State of the art reviews: relationship between diet/physical activity and health. Am J Lifestyle Med. 2007;1(6):457–81.

    Google Scholar 

  111. Wolf AM, Conaway MR, Crowther JQ, Hazen KY, Nadler JL, Oneida B, et al. Translating lifestyle intervention to practice in obese patients with type 2 diabetes: Improving Control with Activity and Nutrition (ICAN) study. Diab Care. 2004;27(7):1570–6.

    Google Scholar 

  112. Verheijden MW, Kok FJ: Public health impact of community-based nutrition and lifestyle interventions. Eur J Clin Nutr, 2005, 59(Suppl. 1): S66–S75; discussion S76

    Google Scholar 

  113. Franz MJ. Carbohydrate and diabetes: is the source or the amount of more importance? Curr Diab Rep. 2001;1:177–86.

    PubMed  CAS  Google Scholar 

  114. Chandalia M, Garg A, Luthohann D, et al. Beneficial effects of a high dietary fiber intake in patients with type 2 diabetes. N Engl J Med. 2000;342:1392–8.

    PubMed  CAS  Google Scholar 

  115. Gannon MC, Nuttall JA, Damberg G, et al. Effect of protein ingestion on the glucose appearance rate in people with type 2 diabetes. J Clin Endocrinol Metab. 2001;86:1040–7.

    PubMed  CAS  Google Scholar 

  116. CAM and Diabetes: A Focus on Dietary Supplements, NCCAM Publication No. D416, June 2008.

    Google Scholar 

  117. WHO. Global Strategy on Diet, Physical Activity and Health. Diet and Physical Activity: A Public Health Priority. 2006 www.who.int/dietphysicalactivity/en/. Accessed July 2009.

  118. WHO. Global Strategy on Diet, Physical Activity and Health. Promoting Fruit and Vegetable Consumption around the World. 2006. www.who.int/dietphysicalactivity/fruit/en/index.html. Accessed July 2009.

  119. Bazzano LA, Serdula M, Liu S. Prevention of type 2 diabetes by diet and lifestyle modification. J Am Coll Nutr. 1 Oct 2005;24(5):310–9.

    PubMed  Google Scholar 

  120. National Academy of Sciences Institute of Medicine. Report offers new eating and exercise targets to reduce chronic disease risk. Available at: http://www4.national.

  121. academies.org/news.nsf/isbn/0309085373?OpenDocument. Accessed 9 Sept 2002.

  122. US Department of Health and Human Services, Centres for Disease Control and Prevention. Overweight and Obesity: Economic Consequences. 2006 www.cdc.gov/NCCDPHP/DNPA/obesity/economic_consequences.htm/. Accessed July 2009.

  123. Segal-Isaacson CJ, Carello E, Wylie-Rosett J. Dietary fats and diabetes mellitus: Is there a food fat? Curr Diab Rep. 2001;1:161–9.

    PubMed  CAS  Google Scholar 

  124. Hegsted DM, Ausman LM, Johnson JA, Dallal GE. Dietary fat and serum lipids: an evaluation of the experimental data. [Published erratum appears in Am J Clin Nutr58:245, 1993]. Am J Clin Nutr. 1993;57:875–83.

    Google Scholar 

  125. Simpson RW, Mann JI, Eaton J, Moore RA, Carter R, Hockaday TDR. Improved glucose control in maturity-onset diabetes treated with high-carbohydrate-modified fat diet. BMJ. 1979;1:1753–6.

    PubMed  CAS  Google Scholar 

  126. Abbott WGH, Boyce VL, Grundy SM, Howard BV. Effects of replacing saturated fat with complex carbohydrate in diets of subjects with NIDDM. Diab Care. 1989;12:102–7.

    CAS  Google Scholar 

  127. Brunzell JD, Lerner RL, Porte D, Bierman EL. Effect of a fat free, high carbohydrate diet on diabetic subjects with fasting hyperglycemia. Diabetes. 1974;23:138–42.

    PubMed  CAS  Google Scholar 

  128. Wolever TM, Hamad S, Gittelsohn J, Gao J, Hanley AJ, Harris SB, et al. Low dietary fiber and high protein intakes associated with newly diagnosed diabetes in a remote aboriginal community. Am J Clin Nutr. 1997;66:1470–4.

    PubMed  CAS  Google Scholar 

  129. Meyer KA, Kushi LH, Jacobs Jr DR, Slavin J, Sellers TA, Folsom AR. Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr. 2000;71:921–30.

    PubMed  CAS  Google Scholar 

  130. Institute of Medicine Food and Nutrition Board. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington, DC: National Academy Press; 2000.

    Google Scholar 

  131. Institute of Medicine Food and Nutrition Board. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: National Academy Press; 2001.

    Google Scholar 

  132. Mooradian AD, Failla M, Hoogwerf B, Maryniuk M. Wylie-Rosett: selected vitamins and minerals in diabetes. Diab Care. 1994;17:464–79.

    CAS  Google Scholar 

  133. Mayer EJ, Newman B, Quesenberry CP, Friedman GD, Selby JV. Alcohol consumption and insulin concentrations: role of insulin in associations of alcohol intake with high-density lipoprotein cholesterol and triglycerides. Circulation. 1993;88:2190–7.

    PubMed  CAS  Google Scholar 

  134. Facchini F, Chen Y-D, Reaven GM. Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diab Care. 1994;17:115–9.

    CAS  Google Scholar 

  135. Bell RA, Mayer-Davis EJ, Martin MA, D’Agostino RB, Haffner SM. Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. Diab Care. 2000;23:1630–6.

    CAS  Google Scholar 

  136. Vaarala O, Knip M, Paronen J, Hamalainan AM, Muona P, Vaatainen M, et al. Cow’s milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes. 1999;48:1389–94.

    PubMed  CAS  Google Scholar 

  137. Virtanen SM, Hypponen E, Laara E, Vahasalo P, Kulmala P, Savola K, et al. Cow’s milk consumption, disease-associated autoantibodies and type 1 diabetes mellitus: a follow-up study in siblings of diabetic children. Childhood Diabetes in Finland Study Group. Diabet Med. 1998;15:730–8.

    PubMed  CAS  Google Scholar 

  138. Bodington MJ, McNally PG, Burden AC. Cow’s milk and type 1 childhood diabetes: no increase in risk. Diabet Med. 1994;11:663–5.

    PubMed  CAS  Google Scholar 

  139. Norris JM, Beaty B, Klingensmith G, Yu Liping, Hoffman M, Chases HP, Erlich HA, Hamman, Eisenbarth GS, Rewers M. Lack of association between early exposure to cow’s milk protein and beta-cell autoimmunity: Diabetes Autoimmunity Study in the Young. JAMA. 1996;276:609–14.

    Google Scholar 

  140. Diabetes and CAM: A Focus on Dietary Supplements, NCCAM Publication No. D416, http://nccam.nih.gov/health/diabetes/CAM-and-diabetes.htm, Updated June 2009.

  141. Natural Medicines Comprehensive Database. Product monographs. Accessed on 21 Jan 2008.

    Google Scholar 

  142. Halat KM, Dennehy CE. Botanicals and dietary supplements in diabetic peripheral neuropathy. J Am Board Fam Pract. 2003;16(1):47–57.

    PubMed  Google Scholar 

  143. Yeh GY, Eisenberg DM, Kaptchuk TJ, et al. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diab Care. 2003;26(4):1277–94.

    CAS  Google Scholar 

  144. Collins QF, Liu HY, Pi J, et al. Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5′-AMP activated protein kinase. J Biol Chem. 2007;282(41):30143–9.

    PubMed  CAS  Google Scholar 

  145. Fukino Y, Shimbo M, Aoki N, et al. Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers. J Nutr Sci Vitaminol. 2005;51(5):335–42.

    PubMed  CAS  Google Scholar 

  146. Kim J, Formoso G, Li Y, et al. Epigallocatechin gallate, a green tea polyphenol, mediates NO-dependent vasodilation using signaling pathways in vascular endothelium requiring reactive oxygen species and Fyn. J Biol Chem. 2007;282(18):13736–45.

    PubMed  CAS  Google Scholar 

  147. Mackenzie T, Leary L, Brooks WB. The effect of an extract of green and black tea on glucose control in adults with type 2 diabetes mellitus: double-blind randomized study. Metabolism. 2007;56(10):1340–4.

    PubMed  CAS  Google Scholar 

  148. Potenza MA, Marasciulo FL, Tarquinio M, et al. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab. 2007;292(5):E1378–87.

    PubMed  CAS  Google Scholar 

  149. Ryu OH, Lee J, Lee KW, et al. Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diab Res Clin Pract. 2006;71(3):356–8.

    CAS  Google Scholar 

  150. Althuis MD, Jordan NE, Ludington EA, et al. Glucose and insulin responses to dietary chromium supplements: a meta-analysis. Am J Clin Nutr. 2002;76(1):148–55.

    PubMed  CAS  Google Scholar 

  151. Balk EM, Tatsioni A, Lichtenstein AH, et al. Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Diab Care. 2007;30(8):2154–63.

    CAS  Google Scholar 

  152. Office of Dietary Supplements. Chromium. Office of Dietary Supplements Web site. 2008. www.ods.od.nih.gov/factsheets/chromium.asp. Accessed on 21 Jan 2008.

  153. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after Bariatric surgery. N Engl J Med. 2004;351:2683–93.

    PubMed  Google Scholar 

  154. Vlassov VV, Sjöström L. Long-term outcome of Bariatric surgery. N Engl J Med. 2005;352:1495–6.

    PubMed  CAS  Google Scholar 

  155. Flatt PR, Day C, Bailey CJ. Review: Bariatric surgery: to treat diabesity. Br J Diab Vasc Dis. 2009;9:103–7.

    Google Scholar 

  156. Olefsky JM, Kolterman OG, Scarlett JA. Insulin action and resistance in obesity and non insulin-dependent ­diabetes mellitus. Am J Physiol. 1982;243:E15–30.

    PubMed  CAS  Google Scholar 

  157. Campbell PJ, Carlson MG. Impact of obesity on insulin action in NIDDM. Diabetes. 1993;42:405–10.

    PubMed  CAS  Google Scholar 

  158. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA. 12 Sept 2001;286(10):1195–200.

    PubMed  CAS  Google Scholar 

  159. Obesity and Diabetes; The Science Creative Quarterly, Issue 4, 2009.

    Google Scholar 

  160. Proven Link between Obesity and Diabetes. http://www.medicalnewstoday.com/articles/156835.php. Accessed on 9 July 2009.

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine & Clinial Studies, University of Guelph, Guelph, ON, N1G2W1, Canada

    Pankaj Modi (Adjunct Prof.)

Authors
  1. Pankaj Modi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pankaj Modi .

Editor information

Editors and Affiliations

  1. University of Arizona Mel and Enid Zucke, 1295 N. Martin, Tucson, 85724-5155, USA

    Joe K Gerald

  2. Arizona Health Science Center, Mel and Enid Zuckerman College of Public, University of Arizona, 1501 N. Campbell Ave. Room 4335, Tucson, 85724-5155, Arizona, USA

    Ronald Ross Watson

  3. Dept. Nutrition & Dietetics, King's College, Stamford St. 150, London, SE1 9NH, United Kingdom

    Victor R. Preedy

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Modi, P. (2011). Importance and Benefits of Lifestyles Changes Versus Diabetes Drugs in Effective Management of Diabetes. In: Gerald, J., Watson, R., Preedy, V. (eds) Nutrients, Dietary Supplements, and Nutriceuticals. Nutrition and Health. Humana Press. https://doi.org/10.1007/978-1-60761-308-4_26

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-308-4_26

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60761-307-7

  • Online ISBN: 978-1-60761-308-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation